A Study of Olaparib and Durvalumab in Prostate Cancer
Condition(s):Prostate CancerLast Updated:February 8, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:February 8, 2024Terminated
Condition(s):Prostate CancerLast Updated:July 27, 2021Recruiting
Condition(s):Prostatic Neoplasms; Radiosurgery; Quality of LifeLast Updated:March 30, 2023Recruiting
Condition(s):Non-Metastatic Prostate CancerLast Updated:May 27, 2009Completed
Condition(s):Non-Metastatic Prostate CancerLast Updated:December 10, 2010Completed
Condition(s):Prostate CancerLast Updated:January 20, 2021Completed
Condition(s):Prostatic NeoplasmsLast Updated:December 11, 2023Completed
Condition(s):Prostatic Neoplasm; Prostate Cancer; Prostatic AdenocarcinomaLast Updated:May 30, 2017Completed
Condition(s):Biochemical Recurrent Prostate CancerLast Updated:March 28, 2024Recruiting
Condition(s):Prostatic NeoplasmsLast Updated:August 18, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.